Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

P38α/JNK Signaling Restrains Erythropoiesis By Suppressing Ezh2-Mediated Epigenetic Silencing of Bim

Ping Hu, MD PhD, Angel Nebreda, PhD, Helmut Hanenberg, MD, Garrett Kinnebrew, MD, Mircea Ivan, MD PhD, Mervin C. Yoder, MD, Marie-Dominique Filippi, PhD, Hal E. Broxmeyer, PhD, Reuben Kapur, PhD

Blood (2018) 132 (Supplement 1): 3837.

https://doi.org/10.1182/blood-2018-99-117098

Published: 2018

Journal Articles

IL-32γ Induces M2 Macrophage Polarization with Enhanced Ability of Macrophage-Mediated Drug Resistance in Myeloma Cells through STAT3 and NF-κB Activation

Haimeng Yan, Xuanru Lin, MD, Xi Huang, MD, Zhang En Fan, Donghua He, Xu Ruyi, Huiyao Gu, Yi Li, MD, Jingsong He, MD, Qing Yi, MD PhD, Zhen Cai, MD PhD

Blood (2017) 130 (Supplement 1): 1781.

https://doi.org/10.1182/blood.V130.Suppl_1.1781.1781

Published: 2017

Journal Articles

Wogonin Inhibits Angiogenesis Via a c-Myc/Hif-1α–dependent Pathway in Multiple Myeloma

Rong Fu, PhD, Qinglong Guo, PhD, Yan Chen, Master, Huihui Song, PhD, Baoan Chen, PhD Professor

Blood (2014) 124 (21): 5238.

https://doi.org/10.1182/blood.V124.21.5238.5238

Published: 2014

Journal Articles

Conflicts Of Interest In Pharmaceutical Sponsored Research On Erythropoietin Receptors In Cancer: An Updated Analysis

Alyssa Trenery, Samuel Kessler, BA, Van Slooten Eleasa, BS, Akida Lebby, Charles L. Bennett, MD, PhD, MPP, Paul Yarnold, PhD, Paul Ray, DO, MA, Dennis W. Raisch, PhD, MS, RPh, Gowtham Rao, MD, PhD, Peter Georgantopoulos, MPH, MA, LeAnne Norris, PharmD, Simone Boyle, BA, Ashlyn Byrne, Matthew Bialkowski, Oliver Sartor, MD

Blood (2013) 122 (21): 2938.

https://doi.org/10.1182/blood.V122.21.2938.2938

Published: 2013

Journal Articles

Evaluating Conflicts of Interest in Academic Research On Erythropoietin Receptors in the Cancer Setting

Charles Bennett, MD, PhD, MPP, Eleasa vanSlooten, Matthew Bialkowski, Alyssa Trenery, Ashlyn Byrne, Alanna Murday, BS, Paul Yarnold, Zaina Parvez Qureshi, PhD, MPH, A. Oliver Sartor, MD

Blood (2012) 120 (21): 4695.

https://doi.org/10.1182/blood.V120.21.4695.4695

Published: 2012

Journal Articles

Twist-1 Expression Represents a Novel Prognostic Factor in Chronic Myelogenous Leukemia.

Franck Emmanuel Nicolini, MD, PhD, Erika Cosset, MSc, Ghassan Hamdan, MSc, Sandrine Jeanpierre, BSc, Charles Dumontet, MD, PhD, Thibault Voeltzel, PhD, Alain Puisieux, PharmD, PhD, Véronique Maguer-Satta, PhD

Blood (2009) 114 (22): 2592.

https://doi.org/10.1182/blood.V114.22.2592.2592

Published: 2009

Journal Articles

Secretome Analyses of Primary Bone Marrow Fibroblasts Isolated From MGUS and Multiple Myeloma Show a Stepwise Occurrence of Alterations.

Johannes Drach, MD, Astrid Slany, Thomas Mohr, Johannes Griss, Christoph C Zielinski, Christopher Gerner

Blood (2009) 114 (22): 1801.

https://doi.org/10.1182/blood.V114.22.1801.1801

Published: 2009

Journal Articles

CEACAM-1, -3, -6, and -8 Signaling in Human Neutrophils

Keith M. Skubitz, MD, Amy P.N. Skubitz

Blood (2008) 112 (11): 4651.

https://doi.org/10.1182/blood.V112.11.4651.4651

Published: 2008

Journal Articles

Effect of New Institutional Algorithm for Chemotherapy Induced Anemia (CIA) on Erythropoiesis-Stimulating Agent Treatment Patterns and Costs in Lymphoma Patients

Aditya D. Raju, M.S., Lal S. Lal, PhD, Lesley-Ann Miller, PhD, Hua Chen, PhD, Sujit S Sansgiry, PhD

Blood (2008) 112 (11): 1299.

https://doi.org/10.1182/blood.V112.11.1299.1299

Published: 2008

Journal Articles

Inhibition of T-Cell Activation by a CEACAM1 (CD66a) Peptide

Keith M. Skubitz, M.D., Amy P.N. Skubitz, Ph.D., Robert Kammerer, Ph.D., D.V.M.

Blood (2008) 112 (11): 4917.

https://doi.org/10.1182/blood.V112.11.4917.4917

Published: 2008

Journal Articles

TNF-α-Mediated Tumor Promotion Is Characterized by Enhanced Vasculogenesis and Generation of Myeloid/Endothelial Vascular Leukoctyes.

Bin Li, PhD, Matthew Pagni, BA, Justin Cates, PhD, D. Brent Polk, MD, Pampee P. Young, MD, PhD

Blood (2007) 110 (11): 3905.

https://doi.org/10.1182/blood.V110.11.3905.3905

Published: 2007

NARROW

P38α/JNK Signaling Restrains Erythropoiesis By Suppressing Ezh2-Mediated Epigenetic Silencing of Bim

IL-32γ Induces M2 Macrophage Polarization with Enhanced Ability of Macrophage-Mediated Drug Resistance in Myeloma Cells through STAT3 and NF-κB Activation

Wogonin Inhibits Angiogenesis Via a c-Myc/Hif-1α–dependent Pathway in Multiple Myeloma

Conflicts Of Interest In Pharmaceutical Sponsored Research On Erythropoietin Receptors In Cancer: An Updated Analysis

Evaluating Conflicts of Interest in Academic Research On Erythropoietin Receptors in the Cancer Setting

Twist-1 Expression Represents a Novel Prognostic Factor in Chronic Myelogenous Leukemia.

Secretome Analyses of Primary Bone Marrow Fibroblasts Isolated From MGUS and Multiple Myeloma Show a Stepwise Occurrence of Alterations.

CEACAM-1, -3, -6, and -8 Signaling in Human Neutrophils

Effect of New Institutional Algorithm for Chemotherapy Induced Anemia (CIA) on Erythropoiesis-Stimulating Agent Treatment Patterns and Costs in Lymphoma Patients

Inhibition of T-Cell Activation by a CEACAM1 (CD66a) Peptide

TNF-α-Mediated Tumor Promotion Is Characterized by Enhanced Vasculogenesis and Generation of Myeloid/Endothelial Vascular Leukoctyes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only